Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

98.39
-6.9600-6.61%
Post-market: 99.000.6100+0.62%19:59 EDT
Volume:1.01M
Turnover:101.48M
Market Cap:23.59B
PE:-45.45
High:104.76
Open:103.53
Low:98.25
Close:105.35
Loading ...

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)

TIPRANKS
·
24 Feb

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Benzinga
·
24 Feb

Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment

Dow Jones
·
24 Feb

Invivyd's Request to Treat Covid-19 Patients With Pemgarda Rejected by US FDA

MT Newswires Live
·
24 Feb

FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existing PEMGARDA EUA for Pre-Exposure Prophylaxis of COVID-19 in Certain Immunocompromised Patients

GlobeNewswire
·
24 Feb

BNTX Insider Trade Alert! Co-Founder and CEO Sells BioNTech Stock Worth $119M

TIPRANKS
·
24 Feb

NSW land values just hit $3trn. Why the record high is ‘not healthy’

The Australian Financial Review
·
24 Feb

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Motley Fool
·
24 Feb

Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test

MT Newswires Live
·
22 Feb

Co-Diagnostics withdraws 510k application to FDA for Co-Dx PCR COVID-19 Test

TIPRANKS
·
22 Feb

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

PR Newswire
·
22 Feb

JTC Corporation appoints Jacqueline Poh as new chief executive

CNA
·
21 Feb

Grieg Seafood Executives Increase Shareholdings, Signaling Confidence in Company’s Future

TIPRANKS
·
21 Feb

Maria Hedengren and Andreas Anyuru Proposed as New Board Members of Smart Eye AB

ACCESS Newswire
·
21 Feb

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
20 Feb

The 7.2% return this week takes BioNTech's (NASDAQ:BNTX) shareholders five-year gains to 271%

Simply Wall St.
·
19 Feb